GMAB

Conviction 57HealthcareScan · Mon, Aug 10, 2026

GMAB$30.86-1.25%

ResistanceSupportVol 14Congress buyCongress sell

Vol MA14 2.03M

May 11May 28Jun 16Jul 6Jul 23Aug 10

GENMAB A/SBiotechnologywww.genmab.com ↗

Price30.86

Change-1.25%

Gap-1.74%

Rel volume0.93×

Avg volume1.91M

Avg $ vol55.86M

SMA 2029.07

SMA 5027.38

SMA 20028.99

Price vs 50+12.70%

Price vs 200+6.45%

MA stackmixed

50/200 cross—

Supertrendup · 28.62

RSI (14)68

MACD hist0.14

MACD crossbull · 1d

Stoch %K / %D75 / 87

ADX (14)15

+DI / −DI34 / 21

RSI divergenceBearish

MACD divergenceBearish

ATR %+2.80%

ADR %2.21%

52w high35.34

52w low21.08

From 52w high-12.68%

Above 52w low+46.39%

New 52w highNo

SqueezeOff

Bollinger width10.44%

%B1.09

Donchian pos76.31%

Donchian high31.79

Donchian low27.87

AVWAP (52w high)28.20

vs AVWAP high+9.44%

AVWAP (52w low)28.97

vs AVWAP low+6.52%

OBV trendUp

Chaikin MF (20)0.17

Today vs 20d0.93×

Avg vol (14d)2.03M

Avg vol (20d)1.91M

Avg $ vol (20d)55.86M

Market cap15.4B

RS 3m (vs SPY)+9.79%

RS 6m (vs SPY)-13.21%

RS line new highYes

Trend template5/8

Technical rank64.3

1 week+7.60%

1 month+6.41%

3 months+16.76%

6 months-0.13%

1 year+36.01%

YTD-3.02%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target38.86

Target upside25.92%

Analyst ratingBuy

Institutional13.42%

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out623.53M

Employees3.09K

ListedTue, Oct 5, 2010

Free float585.99M

Float %94.0%

Short interest7.56M

Days to cover3.2d

Short volume41.1%

Squeeze score19 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.54 vs $0.37

Last surprise+46.0% beat

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank64.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance29.59

Support24.71

Days since event—

Candle confirm—

News sentiment—

Signal lifecycle

How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 15 – Aug 5
8 scans
→
Breaking out now
Aug 6
1 scan

Congress activity

Disclosed STOCK Act trades in GMAB · 5 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Alan Armstrong senate · R · OK · traded 2026-03-30	Buy	$1K–$15K	2026-03-30	2026-07-21	PDF
Josh Gottheimer house · D · NJ · traded 2025-01-16	Buy	$1K–$15K	2025-01-16	2025-02-10	PDF
Josh Gottheimer house · D · NJ · traded 2024-12-16	Sell	$1K–$15K	2024-12-16	2025-01-14	PDF
Josh Gottheimer house · NJ · traded 2024-07-19	Buy	$1K–$15K	2024-07-19	2024-08-12	PDF
Josh Gottheimer house · NJ · traded 2024-06-18	Sell	$1K–$15K	2024-06-18	2024-07-08	PDF

Insider activity

SEC Form 4 transactions in GMAB

No recent insider (Form 4) filings in GMAB. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GMAB · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.